Bliss GVS Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bliss GVS Pharma Ltd. on BSE

Load latest

Bliss GVS Pharma Ltd.

22 Aug 2024

124.22

2.79%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the company has received letters via email from the Stock Exchanges dated August 21, 2024 have each imposed a fine on the Company for non-compliance with Regulation 17(1A) of the SEBI Listing Regulations. Please be informed that the Company is actively addressing this issue by applying for a waiver and even appleaing to the appropriate appellate authority, if required.

pdf

Bliss GVS Pharma Ltd.

14 Aug 2024

124.22

2.79%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We like to inform you that the ESOP Committee of the Company at its meeting held on August 14, 2024, has approved the allotment of 64,150 equity shares of the face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019 ("Bliss GVS ESOP-2019")

pdf

Bliss GVS Pharma Ltd.

14 Aug 2024

124.22

2.79%

Corp. Note

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Enclosed herewith the details of loss of share certificate.

pdf

Bliss GVS Pharma Ltd.

07 Aug 2024

124.22

2.79%

Corp. Note

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Enclosed herewith the details of loss of share certificate.

pdf

Bliss GVS Pharma Ltd.

02 Aug 2024

124.22

2.79%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Enclosed herewith copies of the newspaper advertisement of the notice published in The Free Press Journal (English) and Navshakti (Regional) on August 02, 2024, concerning the proposed transfer of unclaimed final dividend 2016-2017 and its corresponding shares to IEPF Authority.

pdf

Bliss GVS Pharma Ltd.

02 Aug 2024

124.22

2.79%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend …

BSE India

Enclosed herewith a copy of the communication sent to those concerned shareholders, whose dividends have remained unclaimed for a period of seven consecutive years or more, concerning the proposed transfer of unclaimed final dividend 2016-2017 and its corresponding shares to the IEPF Authority.

pdf

Bliss GVS Pharma Ltd.

30 Jul 2024

124.22

2.79%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith the copies of the newspaper advertisement published regarding the extract of the statement of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, in ''The Ecconomics Times & The Free Press Journal'' an English Daily and ''Maharashtra Times & Navshakti'' a Regional Daily on June 26, 2024.

pdf

Bliss GVS Pharma Ltd.

26 Jul 2024

124.22

2.79%

Corp. Note

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that our Registrar and Transfer Agent viz. Link Intime India Private Limited has informed us regarding the loss of share certificates and request for the issue of share certificates from the shareholder.

pdf